Johnson & Johnson (JNJ)
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
JNJ Stock's Re-Rating: When The Market Finally Sees A Different Company
Question: What caused JNJ stock to rise 70% since early 2025?
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Johnson & Johnson said the FDA has approved its once-daily psoriasis pill Icotyde. Icotyde targets IL-23, rivaling best-selling shots Tremfya and Skyrizi.
J&J or Merck? Key Factors Investors Must Weigh Right Now
Johnson & Johnson JNJ and Merck MRK are among the top U.S. healthcare giants, making them ideal candidates for a direct comparison.
US FDA approves J&J's oral psoriasis pill
The U.S. Food and Drug Administration has approved Johnson & Johnson's oral pill for psoriasis, the company said on Wednesday, paving the way for a more convenient treatment option for patients with the chronic autoimmune condition that causes itchy, scaly, and inflamed patches of skin.
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade
Johnson & Johnson (JNJ) reached $238.11 at the closing of the latest trading day, reflecting a -2.09% change compared to its last close.
Why One Analyst Thinks Johnson & Johnson Reaches $280
Johnson & Johnson ( NYSE:JNJ ) has been one of healthcare's standout performers over the past year, with shares up 48% over the past 12 months and 16% year-to-date.
Johnson & Johnson $JNJ Shares Bought by Brown Brothers Harriman & Co.
Brown Brothers Harriman and Co. raised its holdings in Johnson and Johnson (NYSE: JNJ) by 2.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 374,940 shares of the company's stock after purchasing an additional 8,665 shares during the quarter. Brown Brothers Harriman
Bank of Hawaii Reduces Stock Holdings in Johnson & Johnson $JNJ
Bank of Hawaii decreased its position in Johnson and Johnson (NYSE: JNJ) by 5.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,571 shares of the company's stock after selling 2,152 shares during the period. Bank of
Johnson & Johnson (JNJ) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
The 5 Safest Dividend Kings Are the Only Stocks to Buy Now
The stock market could face serious trouble as 2026 heads into the second quarter under duress.
American Investment Services Inc. Purchases 2,152 Shares of Johnson & Johnson $JNJ
American Investment Services Inc. raised its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 10.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,697 shares of the company's stock after purchasing an additional 2,152 shares during the quarter.
